Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4/A Registration of securities issued in business combination transactions
- 5.2 Exhibit 5.2
- 8.1 Exhibit 8.1
- 10.14 Exhibit 10.14
- 10.15 Exhibit 10.15
- 10.16 Exhibit 10.16
- 10.18 Exhibit 10.18
- 10.19 Exhibit 10.19
- 10.20 Exhibit 10.20
- 10.21 Exhibit 10.21
- 23.1 Exhibit 23.1
- 23.2 Exhibit 23.2
- 99.1 Exhibit 99.1
- Download Excel data file
- View Excel data file
Associated filings
- 5 Jun 24 RW Registration withdrawal request
- 2 Jan 24 424B3 Prospectus supplement
- 2 Jan 24 EFFECT Notice of effectiveness
- 29 Dec 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 29 Dec 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 20 Dec 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 17 Nov 23 UPLOAD Letter from SEC
-
3 Nov 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 11 Oct 23 UPLOAD Letter from SEC
- 12 Sep 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 7 Jul 23 S-4 Registration of securities issued in business combination transactions
OTEC similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in this Amendment no. 2 to Registration Statement on Form S-4 (File No. 333-273186) of our report dated July 7, 2023 relating to the financial statements of Regentis Biomaterials Ltd. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
Brightman Almagor Zohar & Co
Certified Public Accounts
A Firm in the Deloitte Global Network
Tel Aviv, Israel
November 3, 2023